Neon Therapeutics Inc (NTGN_old)

NASDAQ
3.070
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    2.915 - 3.090

NTGN_old Overview

Prev. Close
3.07
Day's Range
2.915-3.09
Revenue
-
Open
2.96
52 wk Range
0.88-3.35
EPS
-2.68
Volume
0
Market Cap
88.93M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,609,767
P/E Ratio
-
Beta
-
1-Year Change
0%
Shares Outstanding
28,966,658
Next Earnings Date
-
What is your sentiment on Neon Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Neon Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary

Neon Therapeutics Inc Company Profile

Neon Therapeutics Inc Company Profile

Employees
71

BioNTech US Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It offers NEO-PV-01, a neoantigen vaccine that is in Phase Ib clinical trial for the treatment of advanced and metastatic non-small cell lung cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; NEO-SV-01, a neoantigen vaccine for the treatment of hormone-receptor-positive breast cancer; and NEO-STC-01, a neoantigen adoptive T cell therapy for the treatment of cancers driven or mediated by RAS mutations. The compay was formerly known as Neon Therapeutics, Inc. and changed its name to BioNTech US Inc. in May 2020. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts. As of May 6, 2020, BioNTech US Inc. operates as a subsidiary of BioNTech SE.

Read More
  • position @ 3.12 let's see how high
    0
    • Joshua, today, 17/3/20 price at 1.83, if you have not hit an automatic stop-loss, your stock already loss about 40%
      0
  • Just found this stock !!! Let’s see how it goes! No balance sheet so earnings will be a big deal ha
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.